Branchton, Canada

Martin Ehlert


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Martin Ehlert: Innovator in Pharmaceutical Chemistry

Introduction

Martin Ehlert is a notable inventor based in Branchton, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of acid addition salts of organic bases. With a total of 2 patents to his name, Ehlert's work has implications for the development of various pharmaceutical compounds.

Latest Patents

Ehlert's latest patents include innovative processes for the preparation of acid addition salts. The first patent details a method for preparing acid addition salts of amine bases through solid phase-gas phase reactions. This process involves exposing the organic base in solid form to a gaseous acid, with specific exclusions for ziprasidone and its related compounds. The second patent focuses on the preparation of acid addition salts of ziprasidone and its intermediates, utilizing a similar solid phase-gas phase reaction in a substantially dry environment.

Career Highlights

Ehlert is currently employed at Apotex Pharmachem Inc., where he continues to advance his research in pharmaceutical chemistry. His work is characterized by a commitment to innovation and the development of new methodologies that enhance the efficiency of pharmaceutical production.

Collaborations

Some of Ehlert's notable coworkers include Allan W Rey and Lotfi Derdour. Their collaborative efforts contribute to the dynamic research environment at Apotex Pharmachem Inc.

Conclusion

Martin Ehlert's contributions to pharmaceutical chemistry through his patents and work at Apotex Pharmachem Inc. highlight his role as an innovator in the field. His research continues to pave the way for advancements in drug formulation and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…